14-day Premium Trial Subscription Try For FreeTry Free
$15.00
-0.0300 (-0.200%)
At Close: May 03, 2024
Forecast Earnings Dividends Fundamentals Insider Trading Signals Historical Prices Predictions News Profile

Merrimack Reports Q3 EPS From Continuing Operations $(0.40) vs $(1.88) Est.

 12:00am, Wednesday, 08'th Nov 2017

Merrimack Receives Orphan Drug Designation from the FDA for MM-121 for the Treatment of Heregulin Positive Non-small Cell Lung Cancer

 12:00am, Monday, 30'th Oct 2017

Merrimack Announces Settlement of Convertible Note Litigation, Will Pay Plaintiffs $0.90 per $1 of Convertible Notes, Commence Tender Offer To Acquire All Remaining Convertible Notes At That Rate Plus Accrued Interest

 12:00am, Tuesday, 10'th Oct 2017

Merrimack Pharma Reports Date For 1-for-10 Reverse Split: Effective Sept. 6, 2017

 12:00am, Thursday, 31'st Aug 2017

Merrimack Announces Jean Franchi CFO

 12:00am, Monday, 14'th Aug 2017

Merrimack Pharmaceuticals Holding Shareholder Meeting Today

 12:00am, Friday, 11'th Aug 2017

Merrimack Q2 EPS $(0.03) vs $(0.14) Est.

 12:00am, Wednesday, 09'th Aug 2017

Merrimack Completes Enrollment in Phase II Study for MM-141

 12:00am, Tuesday, 20'th Jun 2017

Why Is Merrimack (MACK) Down 57.6% Since the Last Earnings Report?

 12:00am, Wednesday, 14'th Jun 2017

Merrimack Announces Resignation Of CFO Dr. Yasir Al-Wakeel

 12:00am, Thursday, 25'th May 2017

Merrimack Sees Receiving Up to $33M in Net Milestone Payments within Its Cash Runway

 12:00am, Wednesday, 10'th May 2017

Merrimack Pharmaceuticals (MACK) Gains on Special Dividend

 12:00am, Thursday, 06'th Apr 2017
Click to get the best stock tips daily for free!

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE